[1]
D. Sur, A. Havasi, C. Lungulescu, S. Volovat, C. Burz, and A. Irimie, “Endoglin (CD105) as a putative prognostic biomarker for colorectal cancer: a systematic review”, Medicine and Pharmacy Reports, May 2022.